Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.50
Delayed Data
As of Jun 22
 +0.12 / +1.88%
Today’s Change
4.76
Today|||52-Week Range
8.24
+9.24%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.38
Today’s open6.49
Day’s range6.49 - 6.50
Volume866
Average volume (3 months)5,521
Market cap$30.9M
Dividend yield--
Data as of 3:42pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio54.2
Price/Sales2.70
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
BPMXBiopharmx Corp+0.03+7.70%
CANFCan Fite Biopharma L...-0.02-1.26%
ONSOncobiologics Inc-0.05-4.20%
CSBRChampions Oncology I...+0.02+0.77%
Data as of 4:02pm ET, 06/22/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts